Cochlear Limited

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, PNV.AX has a market cap of 1.01B. Regarding current trading prices, COH.AX is priced at $265.80, while PNV.AX trades at $1.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas PNV.AX's P/E ratio is 146.00. In terms of profitability, COH.AX's ROE is +0.20%, compared to PNV.AX's ROE of +0.08%. Regarding short-term risk, COH.AX is less volatile compared to PNV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, IMR.AX has a market cap of 457.95M. Regarding current trading prices, COH.AX is priced at $265.80, while IMR.AX trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas IMR.AX's P/E ratio is -8.47. In terms of profitability, COH.AX's ROE is +0.20%, compared to IMR.AX's ROE of +4.30%. Regarding short-term risk, COH.AX is less volatile compared to IMR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, EBR.AX has a market cap of 395.20M. Regarding current trading prices, COH.AX is priced at $265.80, while EBR.AX trades at $1.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas EBR.AX's P/E ratio is -5.32. In terms of profitability, COH.AX's ROE is +0.20%, compared to EBR.AX's ROE of -0.91%. Regarding short-term risk, COH.AX is less volatile compared to EBR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, AVH.AX has a market cap of 264.93M. Regarding current trading prices, COH.AX is priced at $265.80, while AVH.AX trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas AVH.AX's P/E ratio is -3.15. In terms of profitability, COH.AX's ROE is +0.20%, compared to AVH.AX's ROE of -0.40%. Regarding short-term risk, COH.AX is less volatile compared to AVH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, AVR.AX has a market cap of 250.63M. Regarding current trading prices, COH.AX is priced at $265.80, while AVR.AX trades at $6.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas AVR.AX's P/E ratio is -1.20. In terms of profitability, COH.AX's ROE is +0.20%, compared to AVR.AX's ROE of -2.19%. Regarding short-term risk, COH.AX is less volatile compared to AVR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, EMV.AX has a market cap of 156.92M. Regarding current trading prices, COH.AX is priced at $265.80, while EMV.AX trades at $1.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas EMV.AX's P/E ratio is -26.21. In terms of profitability, COH.AX's ROE is +0.20%, compared to EMV.AX's ROE of -0.36%. Regarding short-term risk, COH.AX is less volatile compared to EMV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, ARX.AX has a market cap of 153.48M. Regarding current trading prices, COH.AX is priced at $265.80, while ARX.AX trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas ARX.AX's P/E ratio is -22.25. In terms of profitability, COH.AX's ROE is +0.20%, compared to ARX.AX's ROE of -0.08%. Regarding short-term risk, COH.AX is less volatile compared to ARX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, CYC.AX has a market cap of 135.59M. Regarding current trading prices, COH.AX is priced at $265.80, while CYC.AX trades at $1.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas CYC.AX's P/E ratio is -9.38. In terms of profitability, COH.AX's ROE is +0.20%, compared to CYC.AX's ROE of -0.29%. Regarding short-term risk, COH.AX is less volatile compared to CYC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, 4DX.AX has a market cap of 130.66M. Regarding current trading prices, COH.AX is priced at $265.80, while 4DX.AX trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas 4DX.AX's P/E ratio is -2.64. In terms of profitability, COH.AX's ROE is +0.20%, compared to 4DX.AX's ROE of -0.60%. Regarding short-term risk, COH.AX is less volatile compared to 4DX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, SOM.AX has a market cap of 108.05M. Regarding current trading prices, COH.AX is priced at $265.80, while SOM.AX trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas SOM.AX's P/E ratio is -10.00. In terms of profitability, COH.AX's ROE is +0.20%, compared to SOM.AX's ROE of -0.13%. Regarding short-term risk, COH.AX is less volatile compared to SOM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, IPD.AX has a market cap of 68.93M. Regarding current trading prices, COH.AX is priced at $265.80, while IPD.AX trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas IPD.AX's P/E ratio is -3.40. In terms of profitability, COH.AX's ROE is +0.20%, compared to IPD.AX's ROE of -0.58%. Regarding short-term risk, COH.AX is less volatile compared to IPD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, CMP.AX has a market cap of 54.78M. Regarding current trading prices, COH.AX is priced at $265.80, while CMP.AX trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas CMP.AX's P/E ratio is -14.25. In terms of profitability, COH.AX's ROE is +0.20%, compared to CMP.AX's ROE of -0.09%. Regarding short-term risk, COH.AX is more volatile compared to CMP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, RSH.AX has a market cap of 51.98M. Regarding current trading prices, COH.AX is priced at $265.80, while RSH.AX trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas RSH.AX's P/E ratio is -3.30. In terms of profitability, COH.AX's ROE is +0.20%, compared to RSH.AX's ROE of -2.03%. Regarding short-term risk, COH.AX is less volatile compared to RSH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, MX1.AX has a market cap of 41.09M. Regarding current trading prices, COH.AX is priced at $265.80, while MX1.AX trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas MX1.AX's P/E ratio is -3.20. In terms of profitability, COH.AX's ROE is +0.20%, compared to MX1.AX's ROE of -1.06%. Regarding short-term risk, COH.AX is less volatile compared to MX1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, EYE.AX has a market cap of 35.52M. Regarding current trading prices, COH.AX is priced at $265.80, while EYE.AX trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas EYE.AX's P/E ratio is -3.12. In terms of profitability, COH.AX's ROE is +0.20%, compared to EYE.AX's ROE of -0.44%. Regarding short-term risk, COH.AX is less volatile compared to EYE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, CSX.AX has a market cap of 32.82M. Regarding current trading prices, COH.AX is priced at $265.80, while CSX.AX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas CSX.AX's P/E ratio is -21.00. In terms of profitability, COH.AX's ROE is +0.20%, compared to CSX.AX's ROE of -0.08%. Regarding short-term risk, COH.AX is less volatile compared to CSX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, LBT.AX has a market cap of 29.89M. Regarding current trading prices, COH.AX is priced at $265.80, while LBT.AX trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas LBT.AX's P/E ratio is -0.42. In terms of profitability, COH.AX's ROE is +0.20%, compared to LBT.AX's ROE of -1.50%. Regarding short-term risk, COH.AX is more volatile compared to LBT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, NTI.AX has a market cap of 24.14M. Regarding current trading prices, COH.AX is priced at $265.80, while NTI.AX trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas NTI.AX's P/E ratio is -2.30. In terms of profitability, COH.AX's ROE is +0.20%, compared to NTI.AX's ROE of -1.34%. Regarding short-term risk, COH.AX is less volatile compared to NTI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, CDX.AX has a market cap of 21.07M. Regarding current trading prices, COH.AX is priced at $265.80, while CDX.AX trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas CDX.AX's P/E ratio is -0.87. In terms of profitability, COH.AX's ROE is +0.20%, compared to CDX.AX's ROE of -2.72%. Regarding short-term risk, COH.AX is less volatile compared to CDX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, OSL.AX has a market cap of 18.43M. Regarding current trading prices, COH.AX is priced at $265.80, while OSL.AX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas OSL.AX's P/E ratio is -0.40. In terms of profitability, COH.AX's ROE is +0.20%, compared to OSL.AX's ROE of -1.97%. Regarding short-term risk, COH.AX is more volatile compared to OSL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, UBI.AX has a market cap of 15.50M. Regarding current trading prices, COH.AX is priced at $265.80, while UBI.AX trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas UBI.AX's P/E ratio is -1.04. In terms of profitability, COH.AX's ROE is +0.20%, compared to UBI.AX's ROE of -0.70%. Regarding short-term risk, COH.AX is less volatile compared to UBI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, HMD.AX has a market cap of 14.89M. Regarding current trading prices, COH.AX is priced at $265.80, while HMD.AX trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas HMD.AX's P/E ratio is -1.70. In terms of profitability, COH.AX's ROE is +0.20%, compared to HMD.AX's ROE of -2.84%. Regarding short-term risk, COH.AX is more volatile compared to HMD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, TRU.AX has a market cap of 14.43M. Regarding current trading prices, COH.AX is priced at $265.80, while TRU.AX trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas TRU.AX's P/E ratio is -2.60. In terms of profitability, COH.AX's ROE is +0.20%, compared to TRU.AX's ROE of -0.69%. Regarding short-term risk, COH.AX is more volatile compared to TRU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, RNO.AX has a market cap of 11.47M. Regarding current trading prices, COH.AX is priced at $265.80, while RNO.AX trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas RNO.AX's P/E ratio is -1.00. In terms of profitability, COH.AX's ROE is +0.20%, compared to RNO.AX's ROE of +15.91%. Regarding short-term risk, COH.AX is less volatile compared to RNO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, AT1.AX has a market cap of 10.98M. Regarding current trading prices, COH.AX is priced at $265.80, while AT1.AX trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas AT1.AX's P/E ratio is -1.60. In terms of profitability, COH.AX's ROE is +0.20%, compared to AT1.AX's ROE of -0.74%. Regarding short-term risk, COH.AX is less volatile compared to AT1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, CBL.AX has a market cap of 10.31M. Regarding current trading prices, COH.AX is priced at $265.80, while CBL.AX trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas CBL.AX's P/E ratio is -1.17. In terms of profitability, COH.AX's ROE is +0.20%, compared to CBL.AX's ROE of -1.09%. Regarding short-term risk, COH.AX is less volatile compared to CBL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, IRX.AX has a market cap of 5.76M. Regarding current trading prices, COH.AX is priced at $265.80, while IRX.AX trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas IRX.AX's P/E ratio is -2.70. In terms of profitability, COH.AX's ROE is +0.20%, compared to IRX.AX's ROE of +17.09%. Regarding short-term risk, COH.AX is less volatile compared to IRX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, UCM.AX has a market cap of 5.76M. Regarding current trading prices, COH.AX is priced at $265.80, while UCM.AX trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas UCM.AX's P/E ratio is -2.30. In terms of profitability, COH.AX's ROE is +0.20%, compared to UCM.AX's ROE of -0.96%. Regarding short-term risk, COH.AX is more volatile compared to UCM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, ADR.AX has a market cap of 5.31M. Regarding current trading prices, COH.AX is priced at $265.80, while ADR.AX trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas ADR.AX's P/E ratio is -0.17. In terms of profitability, COH.AX's ROE is +0.20%, compared to ADR.AX's ROE of -2.87%. Regarding short-term risk, COH.AX is more volatile compared to ADR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, OVN.AX has a market cap of 4.83M. Regarding current trading prices, COH.AX is priced at $265.80, while OVN.AX trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas OVN.AX's P/E ratio is -0.40. In terms of profitability, COH.AX's ROE is +0.20%, compared to OVN.AX's ROE of -0.80%. Regarding short-term risk, COH.AX is less volatile compared to OVN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, ALT.AX has a market cap of 4.61M. Regarding current trading prices, COH.AX is priced at $265.80, while ALT.AX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas ALT.AX's P/E ratio is N/A. In terms of profitability, COH.AX's ROE is +0.20%, compared to ALT.AX's ROE of -2.31%. Regarding short-term risk, COH.AX is more volatile compared to ALT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, VTI.AX has a market cap of 3.70M. Regarding current trading prices, COH.AX is priced at $265.80, while VTI.AX trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas VTI.AX's P/E ratio is -0.55. In terms of profitability, COH.AX's ROE is +0.20%, compared to VTI.AX's ROE of -0.43%. Regarding short-term risk, COH.AX is more volatile compared to VTI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for COH.AX.

COH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, COH.AX stands at 17.34B. In comparison, AMT.AX has a market cap of 3.47M. Regarding current trading prices, COH.AX is priced at $265.80, while AMT.AX trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

COH.AX currently has a P/E ratio of 46.96, whereas AMT.AX's P/E ratio is -1.45. In terms of profitability, COH.AX's ROE is +0.20%, compared to AMT.AX's ROE of -11.52%. Regarding short-term risk, COH.AX is less volatile compared to AMT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COH.AX.